Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Lawyer wins case against multinational firm behind day school settlement

September 26, 2026

OpenAI pauses training of its ‘most capable models’

September 26, 2026

Kids turned the comment section of an NPR podcast into a group chat

September 26, 2026

BABA 9-DAY DEADLINE ALERT: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 5, 2026 Lead Plaintiff Deadline

September 26, 2026

PNR 6-DAY DEADLINE ALERT: Pentair plc Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 2, 2026 Lead Plaintiff Deadline

September 26, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » The Global Tissue Engineering Market Report 2023
Press Release

The Global Tissue Engineering Market Report 2023

By News RoomDecember 8, 20233 Mins Read
The Global Tissue Engineering Market Report 2023
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) — The “Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, Orthopedics, Musculoskeletal & Spine, Dental, Urology, Cardiology & Vascular), By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global tissue engineering market size is estimated to reach USD 43.13 billion by 2030, growing at an estimated CAGR of 14.28% from 2023 to 2030. Growing incidence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic disorders, has driven the demand for tissue engineering solutions that can repair or replace damaged tissues. Advances in biomaterials, 3D bioprinting, stem cell research, and gene editing techniques have propelled the field of tissue engineering, enabling the development of complex and functional tissues.

The allogeneic tissue transplant method effectively addresses the challenges and limitations associated with the use and accessibility of autologous transplants. In addition, the advancement of specialized procedures, such as implant fixing and sterilization, aimed at converting allogeneic implants into biostatic implants, is anticipated to boost revenue generation in this market.

Tissue regeneration technology is gaining popularity due to its effective products and low rejection rates, leading to an increase in regeneration treatments. Pre-clinical research is currently focused on the use of tissue-engineered vascular grafts in cardiovascular surgery and treatment. Moreover, tissue-engineered bladders can now be successfully implanted outside of the patient’s body. Despite these advancements, the market’s growth is hindered by challenges such as the high cost of product development and ethical concerns surrounding stem cell research and tissue-engineered products.

Tissue Engineering Market Report Highlights

  • In terms of application, the orthopedics, musculoskeletal, and spine segment held the largest revenue share of 59.76% in 2022 owing to the rising prevalence of musculoskeletal disorders. Tissue engineering has emerged as a crucial therapy option for orthopedic surgeons in the management of several musculoskeletal disorders, ranging from meniscal deficits in young athletes to osteochondral abnormalities in the glenohumeral joint
  • The cardiology & vascular segment is anticipated to grow at the fastest CAGR of 25.94% over the forecast period, owing to a rapid increase in the prevalence of cardiovascular disorders globally
  • For the past two decades, cardiac cell therapy or cardiomyoplasty has been a significant focal point in the majority of studies aimed at managing heart disease through regeneration
  • The increasing prevalence of children with congenital malformations, including single ventricle anomalies, has resulted in a rising demand for heart transplantation
  • In terms of region, North America held the largest revenue share of 51.23% in 2022 due to a rise in awareness for stem cell therapy as well as a growing geriatric population
  • Asia Pacific is anticipated to grow at the fastest CAGR of 15.84% over the forecast period due to the presence of untapped opportunities in the emerging economies of China and India
Report Attribute Details
No. of Pages 110
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $14.83 Billion
Forecasted Market Value (USD) by 2030 $43.13 Billion
Compound Annual Growth Rate 14.2%
Regions Covered Global

Companies Mentioned

  • Zimmer Biomet Holdings, Inc.
  • AbbVie (Allergan)
  • Becton, Dickinson and Company
  • B. Braun
  • Integra LifeSciences Corporation
  • Organogenesis Holdings Inc.
  • Medtronic
  • ACell, Inc.
  • Athersys, Inc.
  • Tissue Regenix Group plc
  • Stryker Corporation
  • RTI Surgical, Inc.
  • ReproCell, Inc.
  • Baxter International, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/3vphi3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Tissue Engineering Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

BABA 9-DAY DEADLINE ALERT: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 5, 2026 Lead Plaintiff Deadline

PNR 6-DAY DEADLINE ALERT: Pentair plc Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 2, 2026 Lead Plaintiff Deadline

Upcoming Blaze Wilde Podcast on Snapchat Exploring Pop Culture, Politics, and Life Between Arab and American Culture

Yan’an Apple Price Index Debuts in Shanghai: Unlocking Fair, Quality-Based Fruit Pricing

WSE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Wise Group plc (WSE) Investors of Securities Class Action Lawsuit Deadline on September 29, 2026

Sixthfin Financial Close Management Software Supports UK Internal Control Evidence for Provision 29 and ECCTA Failure-to-Prevent-Fraud Across 38 ERP Systems in 2026

RXT INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Rackspace Technology Investors of Securities Class Action Lawsuit Deadline on September 28, 2026

PNR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Pentair (PNR) Investors of Securities Class Action Lawsuit Deadline on October 2, 2026

CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026

Editors Picks

OpenAI pauses training of its ‘most capable models’

September 26, 2026

Kids turned the comment section of an NPR podcast into a group chat

September 26, 2026

BABA 9-DAY DEADLINE ALERT: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 5, 2026 Lead Plaintiff Deadline

September 26, 2026

PNR 6-DAY DEADLINE ALERT: Pentair plc Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 2, 2026 Lead Plaintiff Deadline

September 26, 2026

Latest News

Kids starting a fire, taking a vehicle set off warning from Mounties in B.C.

September 26, 2026

Upcoming Blaze Wilde Podcast on Snapchat Exploring Pop Culture, Politics, and Life Between Arab and American Culture

September 26, 2026

These are the 15 most affordable cities in Canada, Royal LePage says

September 26, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version